HIV-1 is a master at deceiving the immune system, usurping host biosynthetic machinery. Although HIV-1 is coated with host-derived glycoproteins only glycosylation of viral gp120 has been described. Herein we utilize lectin microarray technology to analyze the glycome of intact HIV-1 virions. We show that the glycan coat of human T-cell line-derived HIV-1 matches that of native immunomodulatory microvesicles. The carbohydrate composition of both virus and microvesicles is cell-line dependent, suggesting a mechanism to rapidly camouflage the virus within the host. In addition, binding of both virus and microvesicles to antiviral lectins is enriched over the host cell, raising concern about targeting these glycans for therapeutics. This work also sheds light on the binding of HIV-1 to galectin-1, an important human immune lectin. Overall, our work strongly supports the theory that HIV-1 co-opts the exocytic pathway of microvesicles, potentially explaining why eliciting a protective antiviral immune response is difficult.
that are also known to bud from the plasma membrane of T-cells and can contaminate viral preparations 6.
Microvesicles, which include endosomally-derived exosomes, are thought to modulate the immune system. Although their specific functions have yet to be defined, such particles have been found to both stimulate and suppress immune responses 7. The enrichment of a select panel of protein markers (<10) in both microvesicles and HIV-1 has led to the hypothesis that these two particles utilize identical machinery to exit the cell, in essence suggesting that HIV-1 is a pathogenic microvesicle 6, 8-10. In T-cells, it has also been shown that microvesicle protein and lipid markers colocalize to discrete microdomains on the plasma membrane with viral gag and are incorporated into virus-like particles, further strengthening the hypothesis 3. Despite this evidence, whether the two particles share an exit mechanism is still a matter of vigorous debate 11.
The cell surface is coated with carbohydrates on both glycoproteins and glycolipids. These glycans are involved in the sorting of both proteins and lipids to membrane microdomains 12-14. Thus, they may act as molecular markers for trafficking pathways. Carbohydrates are critical to HIV-1 biology, influencing the infectivity of the virus 15. However, the glycosylation of HIV-1 has only been studied with regard to the viral glycoprotein gp120 15, which on average is present in ∼20-40 copies per virion 16 . The glycosylation of virionincorporated host proteins, which coat the virus, has largely been ignored and no comparison has been made to the glycome of microvesicles or to the native cell membrane from which both particles arise. A recent advance in glycomic technology, lectin microarrays, has made possible the rapid analysis of the carbohydrate composition of complex biological samples [17] [18] [19] . Herein, we compare the glycomes of HIV-1, microvesicles and the host membranes of the T-cell lines from which they derive. Our work demonstrates a common glycome for HIV-1 and microvesicles that is cell-line dependent and distinct from the host cell membrane, suggesting that the two particles arise from the same microdomain. We also show that both virus and microvesicles bind strongly to antiviral lectins, emphasizing the need for caution in targeting these glycan epitopes for systemic therapeutic applications. In addition, our arrays reveal a potential new binding motif for galectin-1, an important immune lectin, in the context of HIV-1. Overall, our work presents the first glycomic profile of whole HIV-1 virions and microvesicles, adding crucial evidence to support the pathogenic microvesicle theory of HIV-1.
RESULTS

Single color comparison of HIV-1 and MV from H9 cells
For our initial experiments we utilized HIV (HIV-1(MN) CL.4 strain) propagated through the T-cell line H9. HIV-1(MN) CL.4 is a biological clone of HIV-1(MN) that was selected on the basis of high virus yield 20. We compared the glycomic profiles of microvesicles (MV) and cell membrane micellae derived from uninfected H9 cells to HIV using lectin microarrays in a single color format ( Fig. 1a and Supplementary Fig. 1a ) 17 . Previous work has shown that cellular micellae, which originate from isolated cell membranes, contain both glycoproteins and glycolipids and are representative of glycans at the cell surface 17. Our lectin microarrays consisted of ∼70 discrete carbohydrate-binding proteins (Supplementary Table 1 ). Based on the pattern of fluorescent signals and the known glycan-binding properties of the lectins, the carbohydrate composition of the samples was resolved. For safety reasons we chemically inactivated the HIV with 2,2′-dithiodipyridine (1, aldrithiol-2, AT-2) prior to labelling and analysis 21. This procedure eliminates viral infectivity by covalent modification of free cysteine residues on proteins, but does not affect the structure or function of viral glycoproteins on the virion surface 22. We observed no differences in the glycomic analysis of AT-2 treated and untreated microvesicle preparations, indicating that, as expected, the inactivation process does not affect the glycome (Supplementary Fig.  1b) .
Preliminary examination revealed similar glycopatterns for HIV and MV that varied significantly from that of the host cell membrane (Fig. 1a and Supplementary Fig. 1c, d ). Our viral preparation was ∼70-80% pure by both electron microscopy and SDS-PAGE analysis ( Supplementary Fig. 2a, b) , raising concerns that the glycopattern observed might be due to MV contamination. To address this we performed several experiments. First, we tested whether our labelled samples gave signals within the linear range for the majority of lectins at the concentration used in our experiments (∼1 μg). Titration experiments confirmed that at the amounts of both HIV and MV used on our arrays, our signals were in the linear signal range ( Supplementary Fig. 2c, d ). This makes it highly unlikely that similar fluorescence would be observed from the ∼5-fold dilution of protein, and thus glycans, which would be expected if our signal was derived only from the contaminating MV component of the HIV sample. In addition, we examined the glycopattern of virus further purified via CD45 immunodepletion. Recent work has shown that T-cell derived microvesicles contain CD45, thus immunodepletion provides highly pure virions virtually devoid of MV 11, 23 . The glycopattern of this highly purified HIV preparation was identical to that observed for the matched undepleted viral sample, confirming that the pattern derives from the virus and not from contaminating MV (Fig. 1b and Supplementary Fig. 2e and Supplementary Methods).
Closer examination of the single color comparison between the uninfected H9 membrane sample, MV from matched uninfected cells and HIV revealed several striking glycomic features that were conserved between HIV and MV from H9 ( Fig. 1a and Supplementary  Fig. 1d ). Both samples were enriched in high mannose epitopes in comparison to the cell membrane as shown by binding to a series of known anti-viral lectins including GNA, NPA, HHL, PSA, ConA, cyanovirin-N (CVN)24, scytovirin (SVN)25 and griffithsin (GRFT)26, 27. In addition, MV and HIV were enriched in complex N-linked glycans (PHA-L, PHA-E), N-acetyllactosamine (LacNAc, lectins: DSA, MAL-I, RCA, STA, WGA), sialic acid (SNA, MAA, MAL-II) and fucosylated (UEA-I, PTL-II, AAL) epitopes. Our lectin microarray data was in concordance with previous studies focused solely on gp120 glycosylation in HIV-1 propagated through the H9 T-cell line which demonstrate the presence of high mannose, LacNAc, complex N-linked glycans and sialylation on this glycoprotein 28. In contrast, blood group antigens A/B (EEA, LBA), which were present on the host cell, were excluded from both HIV and MV. We confirmed the specificity of the lectin interactions via inhibition experiments using a small panel of carbohydrates ( Supplementary Fig. 3 ). Our data suggests that MV and HIV-1 share a conserved exocytic pathway in which particles incorporate specific cellular glycoproteins as a consequence of budding from discrete domains of the plasma membrane.
Two-color study of HIV-1 and MV from different T-cells
To extend our initial results, we analyzed uninfected cell membrane micellae, corresponding MVs and HIV virions produced from two other T-cell lines, Jurkat-Tat-CCR5 and SupT1 ( Supplementary Figs. 1b and 4 and Supplementary Table 2 ). To facilitate the direct comparison of these samples to H9-derived samples we utilized a more sensitive ratiometric two-color approach in which the H9 cell membrane micellae were used as a common biological reference (Fig. 2a) 17. For each of the three cell lines, we analyzed biological replicates consisting of samples from distinct viral (HIV) or cellular (MV) preparations. Both H9 and SupT1 derived virus were the HIV-1(MN) CL.4 strain while Jurkat-Tat-CCR5 derived virus was the parent HIV-1(MN) strain. We observed a conserved metapattern for both MV and HIV regardless of the parent T-cell line (Fig. 2b, R=0 .66, n=48, P <0.0001). As previously discussed for the single color data, this glycopattern was different from that of the parent cell membranes (Fig. 2b, R=0 .47, P<0.001 and data not shown) and included increased LacNAc, sialic acid and complex and hybrid N-linked glycans on the HIV and MV, and the exclusion of blood group A/B antigen binding from these samples. Surprisingly, HIV clustered more closely with MV from the same parent cell line than with virus propagated through another T-cell line (Fig. 2b , Jurkat-Tat-CCR5, R=0.81; H9, R=0.86; SupT1, R= 0.91). This clustering could be accounted for by cell line dependent differences in a select subset of glycans including β-GalNAc (BPA, CSA, VVA), which was higher in Jurkat-Tat-CCR5-derived HIV and MV, and α-1,2 fucosylated LacNAc (UEA-I, PTA, PTL-II) which was higher in H9-derived HIV and MV. To directly compare the glycomes of our HIV samples, we utilized H9-derived HIV as a reference and hybridized the other HIV samples against it (Fig. 2c ). This data confirmed the previously observed glycosylation differences between HIV samples. Our observation that cell line dependent differences in glycosylation were conserved between the MV derived from uninfected cells and the HIV samples reinforces the theory that MV and HIV-1 share a common exocytic pathway.
Gp120 accounts for glycomic differences of MV and HIV-1
We observed that biological replicates of HIV clustered very tightly (Jurkat-Tat-CCR5, R=0.96; H9, R=0.98, SupT1, R=0.97) and were distinguished from MV from the same cell line by increased high mannose levels (ConA, CVN, GNA, GRFT, HHL, NPA, PSA, SVN, UDA, Fig. 2b and Supplementary Fig. 5a ). It should be noted that in the T-cell lines studied, high mannose epitopes were enriched in MV compared to the host membranes, thus differences in high mannose between HIV and MV represent a further enrichment in these glycans ( Supplementary Fig. 5b ). We questioned whether the differences between MV from uninfected cells and HIV could be accounted for simply by the expression of the highly glycosylated viral envelope glycoprotein gp120, which is known for its characteristic high mannose epitopes 29. To study this, we took advantage of two variants of simian immunodeficiency virus (SIV), SIVmac-NC, which has ∼20 molecules of gp120 per virion, and the related SIVmac-CP, which has approximately 10-fold higher levels (∼200 gp120 molecules per virion) 16, 30. The SIV was obtained from SupT1 host cells, thus first we verified that the SIV samples had a similar glycome to both HIV and MV derived from SupT1 (R= 0.93, n=48, P<0.0001, Fig. 3a) . Next, using MV from uninfected SupT1 cells as a standard, we directly compared the two SIV variants. We observed higher binding to the gp120 enriched SIVmac-CP than to SIVmac-NC for lectins that commonly discriminated between MV and HIV. A select subset of these lectins is shown in Figure 3b . In general, for lectins that did not differentiate between MV and SIVmac-NC, we did not observe enhanced binding for the SIVmac-CP samples, thus this effect was not attributable to differences in sample labelling (AIA, Fig. 3b ). The differences between the SIV variants are most likely a direct consequence of the relative levels of gp120 in the preparations and therefore strongly suggest that the glycomic differences observed between HIV and MV from uninfected cells may be accounted for by the viral envelope glycoprotein gp120.
Glycans on HIV-1 and MV are enriched in cellular microdomains
Our microarray data indicated that HIV-1 and MV bud from discrete membrane microdomains that can be defined by glycan composition. It has been demonstrated in Jurkat cells that N-Rh-PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[lissamine rhodamine B sulfonyl], 2), a fluorescent lipid, labels both microvesicles and membrane microdomains enriched in microvesicle protein markers and HIV-1 gag 3. Therefore we examined whether N-Rh-PE colocalized in microdomains with select fluorescently labelled lectins on the cell surface of our Jurkat-Tat-CCR5 cells. We chose DSA and PHA-L, which bind poly-LacNAc and β-1,6-branched N-linked glycans respectively, due to their increased binding to HIV and MV when compared to Jurkat-Tat-CCR5 cell membrane by microarray analysis (Fig. 4a, and Supplementary Fig. 6a ). As anticipated, both lectins also showed enrichment in specific microdomains on the plasma membrane that colocalized with N-Rh-PE by fluorescence microscopy ( Fig. 4b and Supplementary Fig. 6b ). Lectin staining was glycan dependent as demonstrated by abrogation of the signal upon treatment with PNGase F (Fig. 4c and Supplementary Methods). To confirm the plasma membrane as the site of colocalization, we obtained confocal microscopy images from cells labelled with N-Rh-PE and FITC-conjugated DSA (Supplementary Fig. 6c ). As previously observed, glycan and lipid markers colocalized at the plasma membrane, again validating our microarray data. Given the high degree of similarity between the glycomes of HIV-1 and microvesicles, our data suggests that the two particles emerge from a specific membrane microdomain that can be defined by glycan epitopes as well as protein and lipid content, pointing to glycosylation as a potential sorting determinant for this domain.
Bioinformatics implies galectin-1 binds mannose on HIV-1
Galectin-1 is a human immune lectin that binds to LacNAc and has recently been shown to play a role in promoting HIV-1 infectivity in both T cells and macrophages 31, 32. It is thought to aid absorption of the virus to the cells via a bridging interaction mediated by its two identical carbohydrate-binding domains 32. Closer examination of hierarchical clustering of the lectins in our microarray data revealed galectin-1 at the center of a cluster of lectins that bind to high-mannose epitopes (GNA, NPA, HHL, CVN, SVN, GRFT, R=0.78, n=18, P=0.0001, Fig. 5a,b) , rather than within the cluster of LacNAc binding lectins (LacNAc cluster: MAL-I, RCA, WGA, STA, DSA, R=0.87, P<0.0001, Fig. 5b ). This unexpected result suggested that the binding motif recognized by galectin-1 might be context dependent and in binding HIV-1, galectin-1 may recognize a high mannose epitope. To further probe whether galectin-1 binds to a high mannose glycan on HIV, we inhibited the H9-derived HIV-galectin-1 interaction on our array with either mannose (3) or the commonly used galectin-1 inhibitor lactose (4). We found mannose to be a better inhibitor of galectin-1 binding to HIV (Fig. 5c ) again supporting the idea of interactions via mannose binding. Although we cannot discount the possibility that the immobilization of galectin-1 may have affected the binding of this lectin to glycan epitopes in the context of our arrays, the interactions of microvesicles with galectin-1 could be almost completely inhibited by high concentrations of lactose ( Supplementary Fig. 7a and Supplementary Methods), which demonstrated that the galectin-1 on our arrays was active. In contrast, only moderate inhibition by lactose of the HIV-galectin-1 binding was observed. Mannose, however, was an excellent inhibitor of both HIV and MV binding to galectin-1. This suggests that HIV has a stronger interaction with galectin-1 than MV and that this interaction may be based on binding to a mannose epitope. Given that gp120 has highly clustered mannose epitopes, galectin-1 may recognize high mannose in a context dependent manner on HIV in addition to its known LacNAc recognition motif 33.
The idea that galectin-1 recognizes high mannose on HIV-1 has some precedence in the known interactions of galectins-3 and -10 with mannose-containing epitopes 34, 35, although no such reports exist for galectin-1. Additionally mannose-based inhibitors have been reported for both galectin-3 and -9N, indicating molecular mimicry is possible 36. Careful examination of publicly available carbohydrate array data for galectin-1 protein binding from the Consortium for Functional Glycomics glycan array (www.functionalglycomics.org) also supports our work, revealing binding of galectin-1 to a high mannose epitope at low, but significant, levels ( Supplementary Fig. 7b ) 33, 37. Taken together, this work suggests that galectin-1 binding to HIV-1 may occur through interactions with the clustered high mannose ligands present on the viral surface in addition to its known interactions with LacNAc residues. Given the role of galectin-1 as an important immune lectin, further investigation into whether high mannose is a context dependent galectinbinding motif, as implied by our data, is warranted.
DISCUSSION
The components of the host machinery involved in the biogenesis and egress of HIV-1 are yet to be completely unravelled. Several groups have proposed a shared mechanism for microvesicle and HIV-1 exit 8,9, 38. The remarkable similarity of the carbohydrate cloaks of HIV-1 and microvesicles provides the first glycomic evidence for this hypothesis. Glycosylation plays a key role in protein sorting. Our data suggests that the shared glycome of HIV-1 and MV particles from T-cells may reflect a glycan-dependent protein sorting mechanism, which targets host proteins to microdomains from which both microvesicles and HIV particles emerge (Fig. 4) . It should be noted, however, that protein trafficking pathways are often cell type dependent and thus HIV-1 in other cell types may utilize alternate mechanisms for exit 39.
Although overall the glycopatterns of microvesicles and viral particles from different T-cell lines display a high similarity, subtle glycomic distinctions exist. As a result of these differences, HIV-1 has a closer glycome to the microvesicles derived from the same cell line than to the same strain of HIV-1 propagated in a different T-cell line (Fig. 2) , again supporting the hypothesis that HIV-1 from T-cells is, in essence, a pathogenic microvesicle. This may allow HIV-1 to rapidly alter its infectivity by passaging through different cells. Indeed, variations in the glycosylation of whole viral particles have been shown to alter the infectivity of the related virus SIV 40.
Immune lectins such as DC-SIGN, a dendritic cell surface protein, and MMR (macrophage mannose receptor) are important portals to cell specific infection for HIV-1 41. In addition, recent work has pointed to a role for galectin-1, a soluble innate immune lectin, in HIV-1 pathogenesis. Galectin-1 is thought to aid infectivity of the virus by providing a bridging interaction between the virus and its host cell surface via homodimeric LacNAc binding 31, 32. Our work calls into question the carbohydrate specificity of the galectin-1-HIV-1 interaction, suggesting that high mannose epitopes may be a significant glycan motif for galectin-1 binding in the context of HIV-1. Our discovery of this phenomenon was a direct consequence of our systems-based approach to glycan analysis. The hierarchical clustering of our lectin data and inhibition with mannose, both experiments that would not have been obvious in a traditional study, revealed this unexpected interaction. Interestingly, galectin-1 has been found on the surface of HIV-1 virions derived from macrophages 42. Given that the protein has no transmembrane domain, this suggests that galectin-1 is tightly associated with glycans on the viral surface. If galectin-1 binds to high mannose epitopes in a context dependent-manner, it would have important implications for the recognition of HIV-1 and other pathogens by this critical immune lectin.
Contrary to our expectation that only HIV-1 would contain significant levels of high mannose epitopes, both microvesicles and HIV-1 were enriched in these glycans ( Supplementary Fig. 5 ). The enrichment of high mannose in both of these particles is a concern, as this epitope is a potential target for both anti-viral lectin based therapies and vaccine development 27, 29. However, significantly higher levels of high mannose were in HIV-1 particles (Fig. 2b) . Our data indicates that gp120 is responsible for the differences in glycosylation observed between the microvesicles and HIV-1. This again suggests that HIV-1 has usurped the microvesicle biogenesis pathway in T-cells, hiding from the immune system by wrapping itself in the guise of an immunomodulatory microvesicle. This may contribute to both the dismantling of the immune system by HIV-1 and to the difficulties observed in eliciting a protective immune response to the virus through vaccine strategies 8. Given our lack of knowledge about the role of microvesicles in immune modulation, targeting epitopes, such as high mannose, that functionalize these particles may have unintended negative consequences for the immune system. Our data therefore advocates caution in pursuing this avenue of therapeutic intervention.
supplemented with 2 mM L-glutamine, 10 % fetal bovine serum (Mediatech, Herndon, VA) and penicillin-streptomycin (Invitrogen, Carlsbad, CA) at 37 °C and 5 % CO 2 .
Cell membrane preparation
We prepared labelled cell membrane micellae from uninfected cells as described previously 17. Briefly, cells were pelleted, washed once in PBS (0.1 M phosphate buffer, 0.15 M NaCl, pH 7.4) and resuspended in ice-cold PBS. Cells were then sonicated on ice (3 × 5 s, 70 % power, Branson sonicator with 1/8″ tapered probe tip, Branson, Danbury, CT) to disrupt cell membranes. We then isolated the membranes by pelleting for 1 h at 50,000 rpm using a TLA 100.3 rotor in a Beckman Optima L-80 ultracentrifuge (Beckman Coulter, Fullerton, CA). The pellet was resuspended in Cy buffer (0.1 M Na 2 CO 3 , pH 9.3) and homogenized using a 20 gauge needle ∼ 10 ×. The homogenization was repeated using a 27 gauge needle until complete. We determined the protein concentration using the DC protein assay (BioRad, Hercules, CA) and subsequently fluorescently labelled the sample with Cy3-or Cy5-NHS dyes (60 μg of dye per mg of protein, 45 min, RT with gentle rocking, GE Life Sciences, Piscataway, NJ). Excess dye was then removed by dialyzing (6000-8000 Da MW dialysis tubing) into PBS overnight at 4 °C. We again determined the protein concentration for each sample after dialysis prior to hybridization on the microarrays.
Microvesicles and HIV sample preparation
We collected virus samples from infected cells (H9, HIV-1(MN) CL.4 virions; SupT1, HIV-1(MN) CL.4, SIVmac-NC and SIVmac-CP virions; Jurkat-Tat-CCR5, HIV-1(MN) virions) as previously described 6. We isolated microvesicles from matched uninfected cells. All samples were treated with Aldrithiol-2 21. Samples were resuspended in TNE buffer (0.01 M Tris pH 7.2, 0.1 M NaCl and 1 mM EDTA) and stored at −70 °C prior to labelling.
For fluorescent labelling, pelleted samples (60,000 rpm, 6 min, Beckman TLA-100 centrifuge, TLA100.3 rotor) were resuspended in Cy buffer and then incubated at room temperature for 30 min with Cy3-or Cy5-NHS. Excess free dye was removed from samples by centrifugation through a 20 % sucrose pad (25,000 rpm, 1 h, 4 °C). The pellet was then resuspended in PBS, pelleted (60,000 rpm, 6 min) and diluted in 1 mL of PBS. Labelled samples were stored at −70 °C prior to hybridization to the lectin microarrays.
Manufacture of Lectin microarrays
The lectin microarrays were manufactured as described previously 17, 18 with minor modifications (see Supplementary Table 1 for lectin list, print concentrations and print monosaccharides). All lectins were purchased from EY Laboratories (San Mateo, CA) with the following exceptions: AAL, HHL, RCA, MAL-I, MAL-II, PTL-I and PTL-II were obtained from Vector Labs (Burlingame, CA), cyanovirin, scytovirin, and griffithsin were gifts from Dr. Barry O'Keefe (NCI-Frederick, Frederick, MD) while galectin-1 43 was a gift from Dr. Linda Baum (UCLA Medical School, Los Angeles, CA).
Microarray Hybridization
The microarray slides were fitted to the 16-well FAST frame (Schleicher & Schuell, Keene, NH) to create a separate well for each array resulting in a total of 16 sub-arrays per slide.
For single color experiments, we added 1 μg of labelled sample in a final volume of 100 μL (in PBS with 0.05 %Tween) to each sub-array. Samples were hybridized to the lectin microarrays for 2 h at room temperature with gentle rocking. The individual sub-arrays were then rinsed with PBST (PBS, 0.5 % Tween, 5 × 3 min). After a final rinse in PBS, slides were dried prior to scanning. For ratiometric two-color experiments, we used 1 μg of each orthogonally labelled sample in a total volume of 100 μL. Dye-swapped pairs were hybridized for each sample set using the respective Cy3-and Cy5-labelled pairs. We analyzed slides using a GenePix 4000B fluorescent slide scanner (gain = 400, 5 μm scan, Molecular Devices, Sunnyvale, CA) with GenePix Pro 5.1 software. For details on data analysis see Supplementary Methods.
Fluorescence microscopy
Jurkat cells were labelled with N-Rh-PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[lissamine rhodamine B sulfonyl], Avanti Polar Lipids, Alabaster, AL) at a final concentration of 5 μM in cold RPMI media. Briefly, we made labelling media by adding the fluorescent lipid to cold media in a glass culture tube using a Hamilton syringe and mixing by vigorous shaking. Prior to labelling, Jurkat cells were washed in cold RPMI media. We then mixed the cells with labelling media and incubated at 4 °C for 1 h. The cells were then washed extensively in cold media and cultured in regular media for an additional 20 h at 37 °C 3. For fluorescence microscopy, we adhered the cells to poly-lysine coated glass-bottomed dishes for 5 min at 37 °C and incubated with 5 % BSA in modified PBS (mPBS, 3.8 mM KCl, 1.18 mM KH 2 PO 4 , 1.39 mM NaCl, 3.15 mM Na 2 HPO 4 , 1 mM MgSO 4 ) for 1 h at room temperature (RT). The cells were then fixed in 3 % paraformaldehyde in mPBS for 15 min, RT. We then washed the cells with mPBS (3 × 5 min) followed by incubation with FITC-labelled DSA (Datura stramonium Lectin, EY Labs, 4 μg in 100 μL mPBS + 5 % BSA) or FITC-labelled PHA-L (Phytohemagglutinin-L, EY Labs, 4 μg in 100 μL mPBS + 5% BSA) for 15 min at RT. The cells were subsequently washed with mPBS (3 × 5 min) and images were obtained using an inverted microscope (Nikon Eclipse TE 2000-U; Photometrics CoolSNAP ES monochrome camera) and MetaMorph image analysis software (Version 6.2r6; Molecular Devices) with a 60X oil immersion lens (NA 1.4). FITC and Rhodamine images were obtained using the same dichroic mirror (86012bs, Chroma Technologies, Rockingham Vermont) and separate excitation (ex.) and emission (em.) filters (FITC: ex. S501/16, em S534/30; Rhodamine: ex. S568/24, em. S610/40).
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